Back to Search
MARILYN INTENGAN, MD
MD
Clinical Pathology/Laboratory Medicine Physician
NPI: 1770595563Individual
Specialties, Licenses & Credentials
Clinical Pathology/Laboratory Medicine PhysicianPrimary
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
4301084873(MI)
Research & Publications (10)
Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma.
PMID 16409624·BMC Clin Pathol·2006
8-other
Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.
PMID 16263157·Gynecol Oncol·2006
8-other
Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics.
PMID 15499633·Int J Cancer·2005
4-observational
Tumors of low malignant potential arising in the fallopian tube: case reports.
PMID 15991538·Eur J Gynaecol Oncol·2005
5-case
S-phase modulation by irinotecan: pilot studies in advanced solid tumors.
PMID 15947933·Cancer Chemother Pharmacol·2005
3-trial
Gastrointestinal stromal tumor: chondro-myxoid variant mimicking chondrosarcoma.
PMID 18521413·Sarcoma·2005
8-other
Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma.
PMID 15519528·Eur J Cancer·2004
8-other
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
PMID 14522938·Cancer Res·2003
8-other
Massive localized lymphedema: additional locations and association with hypothyroidism.
PMID 11014586·Hum Pathol·2000
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 JEFFERSON AVE SE
GRAND RAPIDS, MI 49503 - Phone
- (616) 364-6700
Quick Facts
- NPI
- 1770595563
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile